雋思集團(01412.HK)附屬就收購越南土地及廠房建生產基地訂諒解備忘錄
雋思集團(01412.HK)公布,公司的直接全資附屬QP Holdings作為買方,與賣方訂立無法律約束力諒解備忘錄,擬向對方購買一間將於越南註冊成立的目標公司100%股權。為於越南建立集團自有生產基地,公司擬收購賣方目前實益擁有的若干土地、廠房、機器及資產,包括位於越南海陽省的若干部分土地,資產將於收購完成前轉讓予目標公司。
公司擬於越南設立生產基地及購買機器以供生產基地使用。鑒於中國與美國貿易戰的最新發展,公司認為,建議收購將使集團能夠應對貿易戰帶來的影響,並為其美國客戶進行主要產品的端到端生產以及分散經營風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.